Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.01 (-0.39%)
At close: Oct 22, 2026 · 4:00 PM EDT

Protalix BioTherapeutics (PLX) Price to Earnings (2015 - 2026)

Updated

Protalix BioTherapeutics' (PLX) Price to Earnings was 9.91 for Q2 2026, down 47.3% from 18.81 a year earlier and down 13.1% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Price to Earnings (2015 - 2026) Analysis & Trends

For FY2024, Price to Earnings at Protalix BioTherapeutics was 48.64, up 211.3% from FY2023.

  • By year, Price to Earnings came in at 15.62 in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly Price to Earnings since Q3 2016.
  • Year over year, Price to Earnings gained in two of the last four quarters, with growth averaging 93.1%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Protalix BioTherapeutics 207.07 Mn 55.69 Mn 12.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.91
Mar 31, 2026 11.40
Sep 30, 2025 33.10
Jun 30, 2025 18.81
Mar 31, 2025 52.15
Dec 31, 2024 48.64
Mar 31, 2024 13.49
Dec 31, 2023 15.62
Sep 30, 2023 11.41
Jun 30, 2023 16.08
Dec 31, 2020 46.57
Sep 30, 2020 796.38
Sep 30, 2016 1.23
Jun 30, 2016 1.29
Mar 31, 2016 1.51
Dec 31, 2015 1.75
API Access

Protalix BioTherapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PLX&period=max&api_key=YOUR_API_KEY